Retraction: Exosome component 4 promotes epithelial ovarian cancer cell proliferation, migration, and invasion via the Wnt pathway

• June 1, 2026

Four-dimensional computed tomography ventilation imaging-guided radiotherapy planning in different techniques for lung cancer

• by Shu-Qing Yang, Hui Yu, Yu-Long Yang, Cheng Wang, Yan Li, Di-Feng Guo, Chen-Shi Lin, Chao Li, Zhi-Qiang Cai

• June 1, 2026

Perioperative Apalutamide in High-Risk Localized or Locally Advanced Prostate Cancer Reduces Risk of Metastasis and Death

High-risk localized and locally advanced prostate cancer patients treated with apalutamide — a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI) — plus hormone therapy before and after prostate cancer surgery resulted in more major pathologic responses and reduced the risk of metastasis or death, meeting both primary endpoints, in an international phase 3 clinical trial led by principal investigator Mary-Ellen Taplin, MD, medical oncologist at Dana-Farber Cancer Institute, and Adam Kibel, MD, chair of the Department of Urology at Mass General Brigham.

• by

• June 1, 2026

• 4 min

Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study

• by Jun Fang, Siyi Zhong, Tielong Wang, Kang He, Aibo Mu, Meiching Ong, Yimou Lin, Zebin Zhu, Ning Wang, Jiancheng Wu, Zhihao Wang, Zhao Li, Feng Gao, Li Zhuang, Zhiyong Guo, Shusen Zheng, Hao Li, Shugeng Zhang, Qi Ling

• June 1, 2026